North America is expected to dominate the global neurology devices market in the near future
The
prevalence rate of neurological disorders is high around the globe. This factor
is expected to augment the growth of the global neurology devices market over
the forecast period. According to Alzheimer’s Association, around 5.8 million
people in the U.S. aged 65 and older are living with Alzheimer's dementia in
2020. Growing government initiatives in the form of funding in the R&D of
neurological disorders is again uplifting the growth of the neurology devices
market. For instance, in December 2019, the U.S. Congress granted US$ 350
million annual appropriations for R&D in Alzheimer’s and dementia.
Recently, Patients suffering from Covid-19 have reportedly demonstrated
neurologic symptoms, this is expected to create lucrative opportunities for
market growth. For example, in April 2020, researchers at the Union Hospital
and Huazhong University of Science and Technology in Wuhan, China, reported
that over a third of 214 confirmed COVID-19 cases in China had neurologic
symptoms that included acute cerebrovascular events, impaired consciousness,
and muscle injury.
1. In May 2020, Helius Medical Technologies, Inc., a
neurotech company, received Breakthrough Designation for its PoNS device as a
potential treatment for gait deficit due to symptoms of multiple sclerosis.
2. In April 2020, Braintale SAS received CE mark
approval for Brainquant, a quantitative brain measurement device used for
managing patients in a coma following brain injury
3. In December 2019, Raumedic, a medical technology
manufacturer, has launched a new home-use device, named Raumed Home ICP, for
intracranial pressure (ICP) monitoring. The pricing models help align costs
with usage, let hospitals and health systems benefit from the latest
technology, and can lower the overall risk for upgrading technology.
4. In December 2019, Nihon Kohden, a U.S. marketer in
precision medical products and services, announced that it has launched
subscription-based pricing models for its patient monitoring and neurology
products
North
America is expected to dominate the global neurology
devices market over the forecast period and this is accredited to the
growing R &D in neurostimulation devices. For example, in May 2020,
researchers from Stony Brook University, U.S., reported the development of an
analog circuit as a model for multistable brain dynamics, which is expected to
test the efficacy of next-generation neural stimulators.
Neurology
devices are highly advanced devices used to treat various neurological
disorders such as Alzheimer’s, acute spinal cord injury, epilepsy, Parkinson’s,
amyotrophic lateral sclerosis, Bell's palsy, ataxia, brain tumors, cerebral
aneurysm, seizures, and other neurological disorders.
Comments
Post a Comment